Literature DB >> 11936259

Apoptosis: molecular regulation of cell death and hematologic malignancies.

Vincenzo Chiarugi1, Marina Cinelli, Lucia Magnelli, Sbarba Persio Dello.   

Abstract

We describe the molecular mechanisms of apoptosis and its relationships with hematologic malignancies, stressing the concept that, both positive and negative deregulation of apoptosis, may be involved in hematologic human diseases. So, this fundamental process must be balanced by so far unknown mechanisms, involving caspases (cysteine proteases, cleaving the protein substrate after an aspartate residue). These, so far known, ten proteases, are interconnected in a molecular cascade, initiated by the release of cytochrome C from mitochondrial membranes and its interaction with APAF-1 (the homolog of the Caenorhabditis e. CED-4) and with caspase 9, that initiates the proteolitic cascade (1,2). The conclusion is that apoptosis is a very important process, but yet poorly known in molecular details, in spite of the efforts of many scientists. Even the role of bcl-2, the main gene protecting from apoptosis, is still unknown. We close this chapter with a list of ten different technical approaches that can be useful tools to study apoptosis, and tracing the molecular principles on which they are based.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11936259     DOI: 10.1385/mb:20:3:305

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.860


  50 in total

Review 1.  The molecular biology of apoptosis.

Authors:  D L Vaux; A Strasser
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

2.  Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95.

Authors:  A M Chinnaiyan; K O'Rourke; G L Yu; R H Lyons; M Garg; D R Duan; L Xing; R Gentz; J Ni; V M Dixit
Journal:  Science       Date:  1996-11-08       Impact factor: 47.728

3.  A DEVD-inhibited caspase other than CPP32 is involved in the commitment of cerebellar granule neurons to apoptosis induced by K+ deprivation.

Authors:  S R D'Mello; F Aglieco; M R Roberts; K Borodezt; J W Haycock
Journal:  J Neurochem       Date:  1998-05       Impact factor: 5.372

4.  Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation.

Authors:  M L Cleary; S D Smith; J Sklar
Journal:  Cell       Date:  1986-10-10       Impact factor: 41.582

Review 5.  Granzymes: exogenous proteinases that induce target cell apoptosis.

Authors:  M J Smyth; J A Trapani
Journal:  Immunol Today       Date:  1995-04

6.  Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape.

Authors:  M Hahne; D Rimoldi; M Schröter; P Romero; M Schreier; L E French; P Schneider; T Bornand; A Fontana; D Lienard; J Cerottini; J Tschopp
Journal:  Science       Date:  1996-11-22       Impact factor: 47.728

7.  Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome.

Authors:  G H Fisher; F J Rosenberg; S E Straus; J K Dale; L A Middleton; A Y Lin; W Strober; M J Lenardo; J M Puck
Journal:  Cell       Date:  1995-06-16       Impact factor: 41.582

8.  Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule.

Authors:  J Cheng; T Zhou; C Liu; J P Shapiro; M J Brauer; M C Kiefer; P J Barr; J D Mountz
Journal:  Science       Date:  1994-03-25       Impact factor: 47.728

9.  Apaf1 (CED-4 homolog) regulates programmed cell death in mammalian development.

Authors:  F Cecconi; G Alvarez-Bolado; B I Meyer; K A Roth; P Gruss
Journal:  Cell       Date:  1998-09-18       Impact factor: 41.582

10.  Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.

Authors:  Y Gavrieli; Y Sherman; S A Ben-Sasson
Journal:  J Cell Biol       Date:  1992-11       Impact factor: 10.539

View more
  1 in total

1.  Transcriptional regulation of protein complexes and biological pathways.

Authors:  Sridhar Hannenhalli; Samuel Levy
Journal:  Mamm Genome       Date:  2003-09       Impact factor: 2.957

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.